Literature DB >> 27699035

Membranous nephropathy associated with malignant pleural mesothelioma in an adult patient: A case report.

Xinyu Pu1, Yanna Dou1, Dong Liu1, Shan Lu1, Songxia Quan1, Xiaoxue Zhang1, Shuang Ma1, Zhanzheng Zhao1.   

Abstract

A 23-year-old man presented to our hospital with membranous nephropathy and received a detailed examination, including pleural biopsy, due to a feeling of chest oppression. The result of the pleural biopsy was malignant pleural mesothelioma. However, the patient did not have a history of asbestos or tobacco exposure. A review of the English literature identified only 7 reported cases of concomitant malignant mesothelioma and nephrotic syndrome. Furthermore, among the 7 cases reviewed, 6 had a history of asbestos exposure, 1 had a history of prolonged tobacco exposure and in only 1 case the renal pathology results revealed the presence of membranous nephropathy.

Entities:  

Keywords:  malignant pleural mesothelioma; membranous nephropathy; nephrotic syndrome

Year:  2016        PMID: 27699035      PMCID: PMC5038379          DOI: 10.3892/mco.2016.976

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  11 in total

1.  Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma.

Authors:  C K Farmer; D J Goldsmith
Journal:  Postgrad Med J       Date:  2001-05       Impact factor: 2.401

2.  Pleural mesothelioma and membranous nephropathy.

Authors:  K Galesic; B Bozic; R Heinzl; M Scukanec-Spoljar; V Bozikov
Journal:  Nephron       Date:  2000-01       Impact factor: 2.847

3.  Malign peritoneal mesothelioma with nephrotic syndrome.

Authors:  M Dogan; G Ozal; B Savas; M Gungor; G Utkan; B Yalcin; F Icli
Journal:  Bratisl Lek Listy       Date:  2012       Impact factor: 1.278

Review 4.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

5.  Nephrotic syndrome associated with malignant mesothelioma.

Authors:  S Tanaka; H Oda; H Satta; T Takizawa; O Tochikubo; N Takagi; M Ishii; T Kaneko
Journal:  Nephron       Date:  1994       Impact factor: 2.847

6.  [Membranous glomerulonephritis: new insights in pathophysiology and therapeutic approach].

Authors:  Francisco Roberto Lello Santos
Journal:  J Bras Nefrol       Date:  2014 Jan-Mar

7.  Mesothelioma of the testis and nephrotic syndrome: a case report.

Authors:  Justine Bacchetta; Dominique Ranchère; Frédérique Dijoud; Jean-Pierre Droz
Journal:  J Med Case Rep       Date:  2009-06-05

8.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Péchoux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

Review 9.  An autopsy case of malignant pleural mesothelioma associated with nephrotic syndrome.

Authors:  Seiichiro Suzuki; Mikio Toyoshima; Fumiya Nihashi; Hiroe Tsukui; Satoshi Baba; Haruhiko Sugimura; Takafumi Suda
Journal:  Intern Med       Date:  2014       Impact factor: 1.271

10.  Minimal-change nephrotic syndrome associated with malignant mesothelioma.

Authors:  N J Schroeter; D A Rushing; J P Parker; E Beltaos
Journal:  Arch Intern Med       Date:  1986-09
View more
  2 in total

1.  Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma.

Authors:  Kei Nagai; Hiroaki Tachi; Kohei Inoue; Atsushi Ueda
Journal:  Case Rep Nephrol       Date:  2022-09-28

2.  Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab.

Authors:  Jamie S Lin; Daniel Y Wang; Omar Mamlouk; William F Glass; Maen Abdelrahim; Cassian Yee; Ala Abudayyeh
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.